AMRX
USDAmneal Pharmaceuticals Inc. Class A Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$11.010
Máximo
$11.400
Mínimo
$10.940
Volume
3.47M
Fundamentos da empresa
Capitalização de mercado
3.6B
Setor
Drug Manufacturers - Specialty & Generic
País
United States
Estatísticas de negociação
Volume médio
1.66M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Piper Sandler Reiterates Overweight on Amneal Pharmaceuticals, Raises Price Target to $13
Piper Sandler analyst David Amsellem reiterates Amneal Pharmaceuticals with a Overweight and raises the price target from $11 to $13.
Amneal Reports Third Quarter 2025 Financial Results
‒ Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01 ‒‒ Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17 ‒‒ Updated 2025 Full Year Guidance ‒ BRIDGEWATER,
Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved the Company's
Ações relacionadas
MESO
Mesoblast Limited American Depositary Shares
CLMB
Climb Global Solutions Inc.
ATMU
Atmus Filtration Technologies Inc.
BTZ
BlackRock Credit Allocation Income Trust
JHI
John Hancock Investors Trust
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.